Alcohol consumption among HIV-infected women: Impact on time to antiretroviral therapy and survival

Journal of Women's Health

Volumn 20, Issue 2, 2011, Pages 279-286

  Neblett, Robyn C ^a   Hutton, Heidi E ^a   Lau, Bryan ^b   McCaul, Mary E ^a   Moore, Richard D ^a   Chander, Geetanjali ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ILLICIT DRUG; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ALCOHOL CONSUMPTION; ANTIVIRAL THERAPY; COHORT ANALYSIS; COMBINATION ANTIRETROVIRAL THERAPY; CONFERENCE PAPER; DEATH; DEPRESSION; DISEASE ASSOCIATION; DRUG DEPENDENCE; FEMALE; HEPATITIS C; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SURVIVAL; TOBACCO DEPENDENCE;

ADULT; ALCOHOL DRINKING; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ATTITUDE TO HEALTH; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; HIV INFECTIONS; HUMANS; MIDDLE AGED; ODDS RATIO; RISK FACTORS; RISK-TAKING; SEXUAL BEHAVIOR; SURVIVORS; WOMEN'S HEALTH; YOUNG ADULT;

EID: 79951745725     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2010.2043     Document Type: Conference Paper

References (47)

1. Centers for Disease Control and Prevention. HIV=AIDS among women fact sheet (revised 2008). Available at www.cdc.gov=hiv=topics=women=resources= factsheets=pdf=women.pdf Accessed December 9, 2009.
2. Centers for Disease Control and Prevention. HIV=AIDS surveillance report, 2005, Vol. 17 (revised 2007) Atlanta. Available at www.cdc.gov=hiv=topics= surveillance=resources=reports=2005report=pdf=2005SurveillanceReport.pdf Accessed December 9, 2009.
3. Centers for Disease Control and Prevention. HIV=AIDS and African American women consultation: Meeting report, 2007. Available at www.cdc.gov=hiv=topics= aa=resources = reports=women-consult=pdf=womens-consult.pdf Accessed December 9, 2009
4. Centers for Disease Control and Prevention. Summary health statistics for U.S. adults: National Health Interview Survey, 2008. Atlanta. Available at www.cdc.gov=nchs=data = series=sr-10=sr10-242.pdf Accessed June 27, 2010.
5. Samet JH, Cheng DM, Libman H, Nunes DP, Alperen JK, Saitz R. Alcohol consumption and HIV disease progression. J Acquir Immune Defic Syndr 2007;46:194-199. (Pubitemid 47482615)
6. Chander G, Josephs J, Fleishman JA, et al. Alcohol use among HIV-infected persons in care: Results of a multisite survey. HIV Med 2008;9:196-202. (Pubitemid 351467791)
7. Hutton H, McCaul ME, Santora PB, Erbelding EJ. The relationship between recent alcohol use and sexual behaviors: Gender differences among sexually transmitted disease clinic patients. Alcohol Clin Exp Res 2008;32:2008-2015.
8. Theall KP, Clark RA, Powell A, Smith H, Kissinger P. Alcohol consumption, ART usage and high-risk sex among women infected with HIV. AIDS Behav 2007; 11:205-215.
9. Strauss S, Tiburcio N, Munoz-Plaza C, et al. HIV care providers implementation of routine alcohol reduction support for their patients. Aids Patient Care STDS 2009;23:211-218.
10. Conigliaro J, Madenwald T, Bryant K, et al. The Veterans Aging Cohort Study: Observational studies of alcohol use, abuse, and outcomes among human immunodeficiency virus- infected veterans. Alcohol Clin Exp Res 2004;28:313-321. (Pubitemid 38233609)
11. Cook RT. Alcohol abuse, alcoholism, and damage to the immune system: A review. Alcohol Clin Exp Res 1998;22:1927-1942. (Pubitemid 29031009)
12. Meyerhoff DJ. Effects of alcohol and HIV infection on the central nervous system. Alcohol Res Health 2001;25:288-298. (Pubitemid 33708994)
13. Braithwaite RS, McGinnis KA, Conigliaro J, et al. A temporal and dose-response association between alcohol consumption and medication adherence among veterans in care. Alcohol Clin Exp Res 2005;29:1190-1197. (Pubitemid 41060434)
14. Heckman BD, Catz SL, Heckman TG, Miller JG, Kalichman SC. Adherence to antiretroviral therapy in rural persons living with HIV disease in the United States. AIDS Care 2004;16:219-230. (Pubitemid 38183585)
15. Samet JH, Horton NJ, Meli S, Freedberg KA, Palepu A. Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcohol Clin Exp Res 2004;28:572-577. (Pubitemid 38506891)
16. Chander G, Lau B, Moore RD. Hazardous alcohol use: A risk factor for non-adherence and lack of suppression in HIV infection. J Acquir Immune Defic Syndr 2006;43:411-417. (Pubitemid 44737097)
17. Moore RD. Understanding the clinical and economic outcomes of HIV therapy: The Johns Hopkins HIV Clinical Practice Cohort. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17(Suppl 1):S38-41. (Pubitemid 128708058)
18. Helping patients who drink too much. Clinicians guide. 2005 DHHS. NIH. NIAAA. Available at pubs.niaaa .nih.gov=publications=Practitioner= CliniciansGuide2005=guide .pdf Accessed February 16, 2010.
19. Cole SR, Chu H, Greenland S. Multiple imputation for measurement-error correction. Int J Epidemiol 2006;35:1074-1081.
20. Fuchs C, Stampfer M, Colditz G, et al. Alcohol consumption and mortality among women. N Engl J Med 1995;332:1245-1250.
21. Klatsky A, Armstrong M, Friedman G. Alcohol and mortality. Ann Intern Med 1992:117:646-654.
22. Braithwaite R, Conigliaro J, Roberts M, et al. Estimating the impact of alcohol consumption on survival for HIV individuals. AIDS Care 2007;19:459-466. (Pubitemid 46598742)
23. Conen A, Fehr J, Glass TR, et al. Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy, in the Swiss HIV Cohort Study. Antivir Then 2009;14:349-357.
24. Spire B, Lucas G, Carrieri M. Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST). Int J Drug Policy 2007;18:262-270. (Pubitemid 47126278)
25. Wilcox R. Alcohol and HIV: A serious cocktail for transmission and medication adherence. HIV Clinician 2009;21:1-4.
26. Parsons J, Rosof E, Mustanski B. The temporal relationship between alcohol consumption and HIV medication adherence: A multilevel model of direct and moderating effects. Health Psychol 2008;27:628-637.
27. Braithwaite RS, Conigliaro J, McGinnis KA, Maisto SA, Bryant K, Justice AC. Adjusting alcohol quantity for mean consumption and intoxication threshold improves prediction of nonadherence in HIV patients and HIV-negative controls. Alcohol Clin Exp Res 2008;32:1645-1651.
28. Berg KM, Demas PA, Howard AA, Schoenbaum EE, Gourevitch MN, Arnsten JH. Gender differences in factors associated with adherence to antiretroviral therapy. J Gen Intern Med 2004;19:1111-1117. (Pubitemid 39552581)
29. Applebaum AJ, Richardson MA, Brady SM, Brief DJ, Keane TM. Gender and other psychosocial factors as predictors of adherence to highly active antiretroviral therapy (HAART) in adults with comorbid HIV=AIDS, psychiatric and substance- related disorder. AIDS Behav 2009;13:60-65.
30. Lazo M, Gange SJ, Wilson TE, et al. Patterns and predictors of changes in adherence to highly active antiretroviral therapy: Longitudinal study of men and women. Clin Infect Dis 2007;45:1377-1385. (Pubitemid 351411918)
31. Karon JM, Fleming PL, Steketee RW, De Cock KM. HIV in the United States at the turn of the century: An epidemic in transition. Am J Public Health 2001;91:1060-1068. (Pubitemid 32574829)
32. Madeddu G, Porqueddu E, Cambosu F, et al. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era. Infection 2008;36:231-236.
33. Justice C, Lasky E, McGinnis K, et al. Medical disease and alcohol use among veterans with human immunodeficiency infection: A comparison of disease measurement strategies. Med Care 2006;44(Suppl 2):552-560.
34. Spire B, Duran S, Souville M, Leport C, Raffi F, Moatti JP. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: From a predictive to a dynamic approach. Soc Sci Med 2002;54:1481-1496. (Pubitemid 34309013)
35. Li X, Margolick JB, Conover CS, et al. Interruption and discontinuation of highly active antiretroviral therapy in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 2005;38:320-328. (Pubitemid 40333499)
36. Parienti JJ, Massari V, Descamps D, et al. Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy. Clin Infect Dis 2004;38:1311-1316. Epub April 14, 2004. (Pubitemid 38608576)
37. French A, Gawel S, Hershow R, et al. Trends in mortality and causes of death among women with HIV in the United States: A 10-year study. J Acquir Immune Defic Syndr 2009;51:399-406.
38. Cohen M, French A, Benning L, et al. Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy. Am J Med 2002; 113:91-98. (Pubitemid 34804744)
39. Ickovics JR, Hamburger ME, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: Longitudinal analysis from the HIV Epidemiology Research Study. JAMA. 2001;285:1466-1474. (Pubitemid 32221895)
40. Himelhoch S, Moore RD, Treisman G, Gebo KA.Does the presence of a current psychiatric disorder in AIDS patients affect the initiation of antiretroviral treatment and duration of therapy? J Acquir Immune Defic Syndr 2004;37:1457-1463. (Pubitemid 39602335)
41. Chander G, Josephs J, Fleishman JA, et al. Alcohol use among HIV-infected persons in care: Results of a multi-site survey. HIV Med 2008;9:196-202. (Pubitemid 351467791)
42. Campbell J, Hagan H, Latka M, et al. High prevalence of alcohol use among hepatitis C virus antibody-positive injection drug users in three U.S. cities. Drug Alcohol Depend 2006;81:259-265. (Pubitemid 43152452)
43. Peters M, Terrault N. Alcohol use and hepatitis C. Hepatology 2002;36(Suppl 1):S220-225. (Pubitemid 35253484)
44. Bohn MJ, Babor TF, Kranzler HR. The Alcohol Use Disorders Identification Test (AUDIT): Validation of a screening instrument for use in medical settings. J Stud Alcohol 1995;56:423-432.
45. Bradley KA, Bush KR, Epler AJ, et al. Two brief alcoholscreening tests from the Alcohol Use Disorders Identification Test (AUDIT): Validation in a female Veterans Affairs patient population. Arch Intern Med 2003;163:821-829. (Pubitemid 36438054)
46. Sobell LC, Sobell MB. Timeline follow-back: A technique for assessing self-reported ethanol consumption. In: Allen J, Litten RZ, eds. Measuring alcohol consumption: Psychosocial and biological methods. Totowa, NJ: Humana Press, 1992:41-72.
47. Sobell LC, Maisto SA, Sobell MB, Cooper AM. Reliability of alcohol abusers self-reports of drinking behavior. Behav Res Ther 1979;17:157-160. (Pubitemid 9128763)